Moxicloprid 20 25 mg / 1 mL Solution is a Health Canada–registered veterinary drug (DIN 02523655) held by Modern Veterinary Therapeutics LLC, containing Moxidectin. Health Canada lists its status as Dormant (status date 28 Jul 2026). Nexara Health has matched 22 registrations of Moxidectin across 6 other regulated markets.
Health Canada registration
| DIN | 02523655 |
|---|---|
| Brand name | Moxicloprid 20 |
| Active ingredient | Moxidectin |
| Strength | 25 mg / 1 mL |
| Dosage form | Solution |
| Route | Topical |
| Company | Modern Veterinary Therapeutics LLC |
| Status | Dormant — 28 Jul 2026 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Status and company history
Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.
| Date | Field | From | To |
|---|---|---|---|
| 2026-09-03 | Status | Marketed | Dormant |
| 2026-09-03 | Status | Marketed | Dormant |
Moxidectin registered in other markets
22 registrations of the same molecule in 6 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Cydectin Vet. | Zoetis Animal Health ApS | 10 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Cydectin Vet. | Zoetis Animal Health ApS | 1 mg/ml | oral opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Equest Vet. | Zoetis Animal Health ApS | oral gel | MRP | Laegemiddelstyrelsen | |
| Denmark | Ridamec | Chanelle Pharmaceuticals Manufacturing Limited | 1 mg/ml | oral opløsning | MRP | Laegemiddelstyrelsen |
| Hong Kong | Proheart SR-12 Inj Once-A-Year (Vet) | Pah 7v6 Holding Limited | Registered | DH Drug Office | ||
| Iceland | Cydectin | Parlogis - óskráð lyf | 0,1 % | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Cydectin | Parlogis - óskráð lyf | 0,1 % | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Cydectin | Parlogis - óskráð lyf | 0,1 % | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Moxodex | Parlogis - óskráð lyf | 0,1 % | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Moxodex | Parlogis - óskráð lyf | 0,1 % | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Malaysia | Proheart SR-12 10mg/mL Injection For Dogs | Zoetis Malaysia Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Poland | Equimoxin | Bioveta, a.s. | 18,92 mg/g | Żel doustny | Bezterminowe | URPL RPL |
| Poland | Moxisolv LA | Bimeda Animal Health Ltd. | 100 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Moxodex LA | Chanelle Pharmaceuticals Manufacturing Ltd. | 100 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Ridamec | Chanelle Pharmaceuticals Manufacturing Ltd. | 1 mg/ml | Roztwór doustny | Bezterminowe | URPL RPL |
| United States | moxidectin | Chongqing Daxin Pharmaceutical Co. Ltd. | Powder | FDA NDC | ||
| United States | Moxidectin | Zoetis Inc. | Powder | FDA NDC | ||
| United States | Moxidectin | Jetpharma | Powder | FDA NDC | ||
| United States | Moxidectin | Medicines Development for Global Health | Tablet | listed | FDA NDC | |
| United States | Moxidectin | Livzon New North River Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Moxidectin | Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Moxidectin | Hisun Pharmaceutical (Hangzhou) Co., Ltd. | Powder | FDA NDC |
See every manufacturer of Moxidectin worldwide →
Regulator price references for Moxidectin
Published list or reimbursement prices for Moxidectin presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Moxodex | 0.1pct | brusi | 5,740.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Cydectin | 0.1pct | brusi | 6,933.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Moxodex | 0.1pct | brusi | 14,350.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Cydectin | 0.1pct | brusi | 16,195.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Cydectin | 0.1pct | brusi | 37,500.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Moxicloprid 20 (DIN 02523655) marketed in Canada?
No. Health Canada lists DIN 02523655 as Dormant as of 28 Jul 2026.
Who holds the Canadian licence for this product?
Modern Veterinary Therapeutics LLC is the company of record in the Health Canada Drug Product Database.
Is Moxidectin registered outside Canada?
Yes — Nexara Health has matched 22 registrations in 6 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02523655, status date 2026-07-28; national medicine registries: DH Drug Office, FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02523655, status date 2026-07-28; national medicine registries: DH Drug Office, FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra.
Health Canada Drug Product Database (DPD), DIN 02523655, status date 2026-07-28; national medicine registries: DH Drug Office, FDA NDC, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.